Cleerly ISCHEMIA vs BodyGuardian Remote Monitoring System
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a precise, non-invasive diagnostic assessment of coronary artery disease, including detailed plaque characterization and vessel-level ischemia likelihood, derived from CCTA imaging. This tool is ideal for guiding initial treatment strategies and risk stratification in patients with suspected or known coronary artery disease, offering a comprehensive anatomical and functional evaluation.
View Cleerly ISCHEMIA →Choose BodyGuardian Remote Monitoring System if…
Choose BodyGuardian Remote Monitoring System if continuous, ambulatory monitoring is needed to detect and characterize intermittent cardiac arrhythmias over an extended period. This wearable solution is best suited for patients experiencing transient symptoms like palpitations or syncope, or for post-treatment surveillance of known rhythm disorders, providing comprehensive physiological data for accurate diagnosis and management.
View BodyGuardian Remote Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | BodyGuardian Remote Monitoring System |
|---|---|---|
| Pricing | Contact for details | Unknown |
| Deployment | Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) | Cloud-based platform with EMR integration. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
BodyGuardian Remote Monitoring SystemBodyGuardian Remote Monitoring System (Tool B) demonstrates superior usability due to its broad user base, encompassing both patients and physicians. The wearable device emphasizes patient comfort and ease of use, being waterproof and allowing for uninterrupted daily activities, which is crucial for compliance with continuous monitoring. For clinicians, it offers EMR integration and near real-time data access via web portals and mobile applications.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA (Tool A) offers a more profound clinical value by providing a comprehensive, non-invasive diagnostic assessment of coronary artery disease. It delivers detailed plaque characterization, stenosis assessment, and non-invasive fractional flow reserve (FFR) estimation from CCTA scans, directly aiding in personalized diagnosis and treatment planning. Clinical trials like CREDENCE and PACIFIC have validated its high diagnostic accuracy and prognostic utility for major adverse cardiovascular events (MACE) against invasive FFR, establishing it as a significant advancement in non-invasive cardiology.
Pricing & Value
Cleerly ISCHEMIACleerly ISCHEMIA (Tool A) provides more transparency regarding its pricing, with a retail analysis cost of $1500, often discounted to $750, in addition to the CCTA scan cost. Crucially, it is billable under a Category 1 CPTu00ae Code (75580), offering a clear pathway for reimbursement. BodyGuardian Remote Monitoring System (Tool B) has no publicly available pricing information, making it impossible to assess its cost-effectiveness or value proposition.
Enterprise Readiness
BodyGuardian Remote Monitoring SystemBodyGuardian Remote Monitoring System (Tool B) exhibits stronger enterprise readiness with its explicit and extensive EMR integration capabilities, supporting major systems like Epic, Cerner, Meditech, and others. It also highlights a dedicated field-based team for integration and workflow optimization, demonstrating a robust approach to seamless adoption within diverse healthcare IT infrastructures. While Cleerly ISCHEMIA (Tool A) offers API integration with PowerScribe and other upload methods, BodyGuardian's broader EMR compatibility and dedicated integration support give it an edge.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA (Tool A) stands out for its innovative approach to non-invasive cardiac diagnostics. It leverages AI to derive functional information, such as non-invasive fractional flow reserve (FFR) estimation, and detailed coronary plaque characteristics from standard CCTA scans. This capability provides a comprehensive 3D digital model of coronary arteries and vessel-level ischemia likelihood, potentially reducing the need for more invasive procedures and offering a deeper level of insight into coronary artery disease.
Support & Docs
BodyGuardian Remote Monitoring SystemBodyGuardian Remote Monitoring System (Tool B) offers comprehensive support and documentation for both patients and healthcare professionals. This includes 24/7 customer service, detailed patient instruction manuals with how-to videos, FAQs, and specific guidance for billing and travel. Cleerly ISCHEMIA (Tool A) lacks readily available or detailed information regarding its customer support or documentation in the provided sources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | BodyGuardian Remote Monitoring System |
|---|---|---|
| Name | Cleerly ISCHEMIA | BodyGuardian Remote Monitoring System |
| Company | Cleerly | Preventice Technologies (now Boston Scientific Cardiac Diagnostics) |
| Primary Clinical Focus | Non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. | Detection and monitoring of non-lethal cardiac arrhythmias in ambulatory patients. |
| Core Technology/Methodology | FDA-cleared AI tool that analyzes CCTA scans; AI-enabled CCTA analysis; Non-invasive fractional flow reserve (FFR) estimation. | Wearable device collecting and transmitting physiological data; Integrates multiple monitoring technologies (mobile cardiac telemetry, event monitoring, Holter); AI-powered analytics (BeatLogic deep learning AI). |
| Data Input/Analyzed | CCTA scans | ECG, heart rate, respiration rate, and activity level data |
| Key Output/Result | Vessel-level ischemia likelihood determination; Coronary plaque characterization; Stenosis severity assessment; 3D digital models of coronary arteries; Comprehensive interactive web-based reports. | Detection and monitoring of non-lethal cardiac arrhythmias; Wireless data transmission via mobile phone to a cloud-based platform; Physician review via web portal or dedicated mobile application. |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and BodyGuardian Remote Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or BodyGuardian Remote Monitoring System
Backers
Who funded each tool's parent company.